Loading...
Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a german multicenter trial
Gastrointestinal stromal tumors (GIST) are mesenchymal tumors that in the past were classified as leiomyosarcomas or leiomyomas not responding to standard sarcoma chemotherapy. In several phase I and II trials the efficacy and safety of imatinib was shown before the largest trial ever performed in a...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3352192/ https://ncbi.nlm.nih.gov/pubmed/21719393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-783X-16-5-206 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|